Viewing Study NCT07428018

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2026-03-26 @ 3:20 PM
Ignite Modification Date: 2026-06-30 @ 2:17 AM
Study NCT ID: NCT07428018
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-03-05
First Post: 2026-02-17
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer Using Oncotype DX and Abemaciclib
Sponsor: Mario Negri Institute for Pharmacological Research
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Cancer View
None HER2 + Breast Cancer View
None HR Positive View
None Neoadjuvant Therapy View
Keywords:

Keywords

Keyword Brief Keyword Text View
None breast View
None oncotype dx View
None abemaciclib View
None neoadjuvant treatment View
None surgical deescalation View